1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 21 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Platelet nitrate responsiveness in fasting and postprandial type 2 diabetesAnderson, R.; Ellis, G.; Evans, L.; Morris, K.; Chirkov, Y.; Horowitz, J.; Jackson, S.; Rees, A.; Lewis, M.; Frenneaux, M.
2003Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitusPilichiewicz, A.; O'Donovan, D.; Feinle-Bisset, C.; Lei, Y.; Wishart, J.; Bryant, L.; Meyer, J.; Horowitz, M.; Jones, K.
2007Proximal gastric motility in critically ill patients with type 2 diabetes mellitusNguyen, Q.; Fraser, R.; Bryant, L.; Chapman, M.; Holloway, R.
2004Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitusClements, R.; Gonzalez, Q.; Long, C.; Wittert, G.; Laws, H.
2007The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes - Mediation by superoxide production resolution with intensive insulin administrationWorthley, M.; Holmes, A.; Willoughby, S.; Kucia, A.; Heresztyn, T.; Stewart, S.; Chirkov, Y.; Zeitz, C.; Horowitz, J.
2001Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of lifeTalley, N.; Young, L.; Bytzer, P.; Hammer, J.; Leemon, M.; Jones, M.; Horowitz, M.
2008Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population studyQuan, C.; Talley, N.; Jones, M.; Howell, S.; Horowitz, M.
2001Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitusBytzer, P.; Talley, N.; Jones, M.; Horowitz, M.
2008The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitusNatarajan, A.; Marshall, S.; Worthley, S.; Badimon, J.; Zaman, A.
2008Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutideHorowitz, M.; Visboll, T.; Zdravkovic, M.; Hammer, M.; Madsbad, S.

Discover